Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002

And Rules 13a-14 and 15d-14 under the Securities and Exchange Commission

I, Terrance J. Bruggeman, certify that:

1.
I have reviewed this Annual Report on Form 10-KSB of Somanta Pharmaceuticals, Inc.;

2. Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this
annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being
prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the registrants board of directors:

(a) all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial
information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrants internal controls over financial reporting.

Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal controls over financial reporting.

Date: July 19, 2006



|    |  |                                                                     
|--- |  | --------------------------------------------------------------------
|    | 
|By: |  | /s/    TERRANCE J.
BRUGGEMAN                                        
|    |  | Terrance J. Bruggeman                                               
|    |  | Executive Chairman, Chief Financial Officer, Treasurer and Secretary